Richard M. Glickman

CIK: 0001352637

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ENGN

enGene Therapeutics Inc.

Director

EPIX

ESSA Pharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ENGN
enGene Therapeutics Inc.
Jun 16, 2026
Award(A)
Stock Option (Right to Buy)
Direct
31K shares-
EPIX
ESSA Pharma Inc.
Oct 9, 2025
Disposition(D)
Direct
43.2K shares-
ENGN
enGene Holdings Inc.
Jun 16, 2025
Award(A)
Stock Option (Right to Buy)
Direct
22.5K shares-

		Type	Shares	Price		Ownership
Jun 16, 2026	ENGN enGene Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	31,000	-	-	Direct
Oct 9, 2025	EPIX ESSA Pharma Inc.	Disposition(D)	43,240	-	-	Direct
Jun 16, 2025	ENGN enGene Holdings Inc.	Award(A) Stock Option (Right to Buy)	22,500	-	-	Direct

1-3 of 3 transactions

About Glickman Richard M

Glickman Richard M (SEC CIK 0001352637) files insider reports with the SEC as Director of enGene Therapeutics Inc. (ENGN) and Director of ESSA Pharma Inc. (EPIX).

Signal8 holds 3 ownership filings by Glickman Richard M, all Form 4s, filed between Jun 16, 2025 and Jun 17, 2026. Those filings report 3 transactions, from Jun 16, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Glickman Richard M's filings is in SAINT-LAURENT.

Recent filings by Glickman Richard M

Jun 16, 2026: Grant or award of ENGN derivative securities (Form 4, code A).
Oct 9, 2025: Disposition to issuer transaction of EPIX shares (Form 4, code D).
Jun 16, 2025: Grant or award of ENGN derivative securities (Form 4, code A).

Other insiders filing for enGene Therapeutics Inc. (ENGN)

Grossman William, Interim Chief Medical Officer
Chinoporos Constantine, Interim Chief Business Officer
Richton Kathleen P., SVP, Finance and Treasurer
Astley-Sparke Philip, Director
BRUNK GERALD A, Director
HASTINGS PAUL J, Director

How to read Form 4 transaction codes